期刊文献+

替比培南匹伏酯侧链的合成 被引量:5

Synthesis of the side chain of tebipenem pivoxil
原文传递
导出
摘要 目的:合成替比培南匹伏酯侧链1-(4,5-二氢-2-噻唑啉基)-3-巯基吖丁啶盐酸盐。方法:以2-甲硫基-2-噻唑啉为原料,经与3-羟基吖丁啶盐酸盐,甲烷磺酰氯,硫代乙酸钾以及水解4步反应合成1-(4,5-二氢-2-噻唑啉基)-3-巯基吖丁啶盐酸盐。结果:合成了1-(4,5-二氢-2-噻唑啉基)-3-巯基吖丁啶盐酸盐,总收率42%。结论:本方法可以方便地得到替比培南匹伏酯侧链1-(4,5-二氢-2-噻唑啉基)-3-巯基吖丁啶盐酸盐,提高了反应收率,简化了操作,降低了成本。 Objective: To synthesize the side chain 1-(4,5-dihydrothiazol-2-yl) azetidine-3-thiol hydrochloride of tebipenem pivoxil.Methods: 1-(4,5-Dihydrothiazol-2-yl) azetidine-3-thiol hydrochloride was prepared from 2-(methylthio)-4,5-dihydrothiazole by a 4-step process,i.e.successively reacted with 3-hydroxyazetidine hydrochloride,methanesulfonyl chloride,potassium ethanethioate and hydrolysis.Results: The total yield of 1-(4,5-dihydrothiazol-2-yl) azetidine-3-thiol hydrochloride was 42%.Conclusion: This method increases the yield of 1-(4,5-dihydrothiazol-2-yl) azetidine-3-thiol hydrochloride,simplifies the process and decreases the cost.
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第4期428-430,共3页 Chinese Journal of New Drugs
关键词 替比培南匹伏酯 1-(4 5-二氢-2-噻唑啉基)-3-巯基吖丁啶盐酸盐 合成 tebipenem pivoxil 1-(4 5-dihydrothiazol-2-yl) azetidine-3-thiol hydrochloride synthesis
  • 相关文献

参考文献6

  • 1张文君,吴文芳,冯小龙.新型口服碳青霉烯类抗菌药物—泰吡培南酯[J].河北医药,2010,32(18):2596-2599. 被引量:19
  • 2MIYAZAKI S, HOSOYAMA T, FURUYA N, et al. In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections[J]. Antimierob Agents Chemother, 2001, 45( 1 ):203- 207.
  • 3KOBAYASHI R, KONOMI M, HASEGAWA K, et al. In vitro activity of Tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae [J]. Antimicrob Agents Chemother, 2005, 49 (3):889- 894.
  • 4YAMADA M, WATANABE T, BABA N, et al. Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneurnoniae [ J ]. Antirnicrob Agents Chemother, 2008, 52 (6) :2053 - 2060.
  • 5ABE T, ISODA T, SATO C, et al. 2-[1-( 1,3-thiazolin-2-yl) azetidine-3-yl] thio-carbapenem derivatives: US, 5534510 [P]. 1996 - 07 - 09.
  • 6HAYASHI K, SATO C, TAMAI S. 1-(4,5-dihydro-2-thiazolyle)- 3-azetidine thiol derivatives: EP, 0717042 [P]. 1996 - 06 - 19.

二级参考文献25

  • 1Abe T,Hayashi K,Mihira A,et al.L-084,a new oral carbapenem:Synthesis and structure-activity relationships of C2substituted 1beta-methylcarbapenems.38th Intersci Conf Antimicrob Agents Chemother (ICAAC),(Sept 24-27,San Diego),1998,Abst F-64.
  • 2Isoda T,Sato C,Mihira A,et al.(Wyeth-Lederle Japan,Ltd.).2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thiocarbapenem derivatives.EP 0632039,EP 0717042,JP 1996053453,US 5534510,US 5659043,US 5783703.
  • 3Kumagai T.(Wyeth-Lederle Japan,Ltd.).Carbapenem-3-carboxylic acid ester derivatives.EP 0808315,JP 1999504039,US 5886172,WO 9721712.
  • 4Yasuda S,Okue M,Hori N.(Meiji Seika Kaisha,Ltd).Process for producing carbapenem derivative and intermediate for use in the production.WO 2004035539.
  • 5Nishino K,Koga T.(Kaneka Corporation).Process for producing carbapenem compound for oral administration.EP 1580191.
  • 6西野敬太,古贺照义.经口给药用碳青霉素烯化合物的新的合成中间体及其制造方法.CN1708504A.
  • 7Kato N,Kato H,Tanaka K,Watanabe K.L-084,a new oral carbapenem:In vitro activity against anaerobic bacteria.38th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 24-27,San Diego),1998,Abst F-70.
  • 8Kobayashi R,Konomi N,Hasegawa K,et al.In vitro antivity of tebipenem,a new oral carbapenem antibiotic,against penicillin-nonsusceptible Streptococcus pneumonia.Antimicrob Agents Chemother,2005,49:889-894.
  • 9Hanaki H,Sasaki K,Inaba Y,et al.L-084,a new oral carbapenem:In vitro activity against clinical isolated strains including vancomycin low-restraint Staphylococcus aureus and its binding affinity to PBPs.38th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 24-27,San Diego),1998,Abst F-66.
  • 10Hikida M,Itahashi K,Igarashi A,et al.In Vitro antibacterial activity of LJC 11,036,an active metabolite of L-084,a new oral carbapenem antibiotic with potent antipneumococcal activity.Antimicrob Agents Chemother,1999,43:2010-2016.

共引文献18

同被引文献18

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部